Echinococcus granulosus cyst fluid inhibits the type I interferon response by promoting ROS in macrophages
Chunxue Fu1, Chun Yang1, Caiya Ni1
1NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital/Shihezi University School of Medicine, Shihezi, Xinjiang, China; Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Insights
Cystic echinococcosis fluid (EgCF) impairs macrophage immunity by increasing reactive oxygen species (ROS), which blocks the cGAS-STING-IRF3 pathway and reduces the type I interferon response. Restoring ROS levels with NAC treatment reactivates this pathway.
Area of Science:
- Immunology
- Parasitology
- Cellular Biology
Background:
- Cystic echinococcosis (CE) is a parasitic infection where Echinococcus granulosus cystic fluid (EgCF) may suppress macrophage immunity.
- The impact of EgCF on the crucial type I interferon (IFN-I) response is not well understood.
Purpose of the Study:
- To investigate whether EgCF affects the type I interferon response in macrophages.
- To elucidate the underlying molecular mechanisms, focusing on the cGAS-STING-IRF3 signaling pathway and reactive oxygen species (ROS).
Main Methods:
- Macrophages were treated with EgCF and stimulated with 2'3'-cGAMP.
- Interferon-beta (IFN-β) production, cGAS-STING-IRF3 signaling activation, and intracellular ROS levels were measured.
- The effect of the ROS inhibitor N-acetylcysteine (NAC) was assessed.
Main Results:
- EgCF significantly reduced 2'3'-cGAMP-induced IFN-β production in macrophages.
- EgCF inhibited the cGAS-STING-IRF3 signaling pathway.
- EgCF treatment led to increased intracellular ROS levels.
- NAC administration restored cGAS-STING-IRF3 signaling and IFN-β expression.
Conclusions:
- EgCF impairs macrophage-mediated type I interferon responses.
- This impairment is mediated by EgCF-induced increases in ROS, which inhibit the cGAS-STING-IRF3 signaling pathway.
Abstract:
In cystic echinococcosis (CE), Echinococcus granulosus cystic fluid (EgCF) could impede macrophage-mediated immunity. However, whether EgCF is implicated in the type I interferon response remains to be established. Here, we revealed that EgCF reduced 2'3'-cGAMP-induced IFN-β production in macrophages by inhibiting the cGAS-STING-IRF3 signaling. EgCF also increased the intracellular reactive oxygen species (ROS) levels. Administration of the ROS inhibitor N-acetylcysteine (NAC) restored the cGAS-STING-IRF3 signaling, which, in turn, upregulated IFN-β expression. The findings disclose that EgCF could increase macrophage ROS levels, thereby blocking cGAS-STING-IRF3 signaling and repressing the IFN-I response.
Related Concept Videos
Amebiasis
Inhibitors of Viral Protein Synthesis


